Previous work has employed Mendelian randomization to study potential biomarkers and adverse effects of inhibiting IL6 signaling.40 Clinical trials investigating IL6 signaling inhibition for the treatment of CVD are already underway16 and the insights generated in our current study may be used to inform similar endeavors for AAA. This evidence concerns the gene IL6 and triple-A syndrome.